Lexeo Therapeutics, Inc.
LXEO
Positions held
Your positionsLXEO isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $263.50M | Enterprise value | $58.46M | Trailing P/E | — | Forward P/E | -2.35 |
| PEG | — | Price / book | 1.07 | Beta | 1.64 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -46.8% | ROA | -27.6% | Debt / equity | 0.03 |
| Current ratio | 13.89 | Free cash flow | -$58.79M | Analyst recommendation | strong_buy | Mean target | $20.30 |
| 52w high | $10.99 | 52w low | $2.98 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$25.9M | -$20.2M | -$20.9M | -$20.3M | -$26.1M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$28.0M | -$22.3M | -$23.1M | -$21.6M | -$30.7M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.7M | — |
| Op margin | — | — | — | -9252.1% | — |
| Net income | -$100.0M | -$98.3M | -$66.4M | -$59.3M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$109M | -$106M | -$68.5M | -$60.5M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
2026-09-23 · Lexeo Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum
2026-09-22 · Lexeo Therapeutics to Acquire Mantle Therapeutics for Up to $21.3 Million; Enters Three Research Collaborations
2026-09-02 · Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
2026-08-12 · Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
2026-07-15 · What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple
Price (daily)
Full chart · RSI · MACD · patterns